Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Human cytomegalovirus (HCMV) represents the major viral complication after hematopoietic stem cell transplantation. HCMV infection may be controlled by the reconstituting immune system and remain subclinical or can lead to severe systemic and/or organ disease (mainly pneumonia and gastroenteritis) when immune reconstitution is delayed or impaired. In order to prevent the occurrence of HCMV disease, a prompt diagnosis of HCMV infection is mandatory. The adoption of pre-emptive therapy strategies guided by virological monitoring dramatically reduced the occurrence of HCMV disease. However, late-onset end-organ disease may occur in some patients with apparent immune reconstitution. In the near future, introduction of immunological monitoring and immunotherapies could markedly improve management of HCMV infection.

Original languageEnglish
Pages (from-to)1135-1149
Number of pages15
JournalImmunotherapy
Volume8
Issue number9
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Adult Stem Cells
Cytomegalovirus Infections
Hematopoietic Stem Cells
Transplants
Cytomegalovirus
Immunologic Monitoring
Hematopoietic Stem Cell Transplantation
Gastroenteritis
Immunotherapy
Transplant Recipients
Immune System
Pneumonia

Keywords

  • hematopoietic stem cell transplantation
  • human cytomegalovirus
  • immune reconstitution
  • pre-emptive therapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients. / Lilleri, Daniele; Gerna, Giuseppe.

In: Immunotherapy, Vol. 8, No. 9, 01.09.2016, p. 1135-1149.

Research output: Contribution to journalReview article

@article{779707a36169458a925aaa2632f20347,
title = "Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients",
abstract = "Human cytomegalovirus (HCMV) represents the major viral complication after hematopoietic stem cell transplantation. HCMV infection may be controlled by the reconstituting immune system and remain subclinical or can lead to severe systemic and/or organ disease (mainly pneumonia and gastroenteritis) when immune reconstitution is delayed or impaired. In order to prevent the occurrence of HCMV disease, a prompt diagnosis of HCMV infection is mandatory. The adoption of pre-emptive therapy strategies guided by virological monitoring dramatically reduced the occurrence of HCMV disease. However, late-onset end-organ disease may occur in some patients with apparent immune reconstitution. In the near future, introduction of immunological monitoring and immunotherapies could markedly improve management of HCMV infection.",
keywords = "hematopoietic stem cell transplantation, human cytomegalovirus, immune reconstitution, pre-emptive therapy",
author = "Daniele Lilleri and Giuseppe Gerna",
year = "2016",
month = "9",
day = "1",
doi = "10.2217/imt-2015-0028",
language = "English",
volume = "8",
pages = "1135--1149",
journal = "Immunotherapy",
issn = "1750-743X",
publisher = "Future Medicine Ltd.",
number = "9",

}

TY - JOUR

T1 - Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients

AU - Lilleri, Daniele

AU - Gerna, Giuseppe

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Human cytomegalovirus (HCMV) represents the major viral complication after hematopoietic stem cell transplantation. HCMV infection may be controlled by the reconstituting immune system and remain subclinical or can lead to severe systemic and/or organ disease (mainly pneumonia and gastroenteritis) when immune reconstitution is delayed or impaired. In order to prevent the occurrence of HCMV disease, a prompt diagnosis of HCMV infection is mandatory. The adoption of pre-emptive therapy strategies guided by virological monitoring dramatically reduced the occurrence of HCMV disease. However, late-onset end-organ disease may occur in some patients with apparent immune reconstitution. In the near future, introduction of immunological monitoring and immunotherapies could markedly improve management of HCMV infection.

AB - Human cytomegalovirus (HCMV) represents the major viral complication after hematopoietic stem cell transplantation. HCMV infection may be controlled by the reconstituting immune system and remain subclinical or can lead to severe systemic and/or organ disease (mainly pneumonia and gastroenteritis) when immune reconstitution is delayed or impaired. In order to prevent the occurrence of HCMV disease, a prompt diagnosis of HCMV infection is mandatory. The adoption of pre-emptive therapy strategies guided by virological monitoring dramatically reduced the occurrence of HCMV disease. However, late-onset end-organ disease may occur in some patients with apparent immune reconstitution. In the near future, introduction of immunological monitoring and immunotherapies could markedly improve management of HCMV infection.

KW - hematopoietic stem cell transplantation

KW - human cytomegalovirus

KW - immune reconstitution

KW - pre-emptive therapy

UR - http://www.scopus.com/inward/record.url?scp=84981237590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981237590&partnerID=8YFLogxK

U2 - 10.2217/imt-2015-0028

DO - 10.2217/imt-2015-0028

M3 - Review article

VL - 8

SP - 1135

EP - 1149

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 9

ER -